Publications
Detailed Information
Fibroblast growth factor-1 as a mediator of paracrine effects of canine adipose tissue-derived mesenchymal stem cells on in vitro-induced insulin resistance models : In vitro 인슐린 저항성 모델에 대한 개 지방유래중간엽줄기세포 paracrine 효과의 매개체 fibroblast growth factor-1
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | 윤화영 | - |
dc.contributor.author | 김현진 | - |
dc.date.accessioned | 2018-05-29T04:40:56Z | - |
dc.date.available | 2018-05-29T04:40:56Z | - |
dc.date.issued | 2018-02 | - |
dc.identifier.other | 000000150026 | - |
dc.identifier.uri | https://hdl.handle.net/10371/142207 | - |
dc.description | 학위논문 (석사)-- 서울대학교 대학원 : 수의과대학 수의학과, 2018. 2. 윤화영. | - |
dc.description.abstract | In the field of diabetes research, many studies on cell therapy have been conducted using mesenchymal stem cells. This research was intended to shed light on the influence of canine adipose-tissue-derived mesenchymal stem cell conditioned medium (cAT-MSC CM) on in vitro insulin resistance models that were induced in differentiated 3T3-L1 adipocytes and the possible mechanisms involved in the phenomenon. Gene expression levels of insulin receptor substrate-1 (IRS-1) and glucose transporter type 4 (GLUT4) were used as indicators of insulin resistance. Relative protein expression levels of IRS-1 and GLUT4 were augmented in the cAT-MSC CM treatment group compared to insulin resistance model controls, indicating beneficial effects of cAT-MSC to DM, probably by actions of secreting factors. With reference to previous studies on fibroblast growth factor-1 (FGF1), it was proposed as a contributing factor to the mechanism of action. Anti-FGF1 neutralizing antibody was added to the CM-treated insulin resistance models. As a result, significantly diminished protein levels of IRS-1 and GLUT4 were observed, supporting our assumption. Accordingly, this study advocated the potential of MSC CM as an alternative insulin sensitizer and discovered a signalling factor associated with the paracrine effects of cAT-MSC. | - |
dc.description.tableofcontents | 1. Introduction 1
2. Material and Methods 3 2.1. Cell culture and characterization 3 2.2. In vitro cellular insulin resistance models 4 2.3. Preparation of cAT-MSC-conditioned medium (CM), and anti-fibroblast growth factor-1 (FGF1) antibody treatment 5 2.4. RNA extraction, cDNA synthesis, and quantitative real-time PCR 5 2.5. Western blot analysis 6 2.6. Statistical analysis 7 3. Results 8 3.1. Characterization of cAT-MSCs 8 3.2. Differentiation into adipocytes and development of an insulin resistance model in 3T3-L1 adipocytes 8 3.3. Effects of cAT-MSC CM treatment on IRS-1 and GLUT4 expressions in the insulin resistance model 8 3.4. Reduced therapeutic effects of cAT-MSC CM with anti-FGF1 neutralizing antibody treatment 9 4. Discussion 11 5. Conclusion 15 References 22 국문초록 32 | - |
dc.format | application/pdf | - |
dc.format.extent | 1110655 bytes | - |
dc.format.medium | application/pdf | - |
dc.language.iso | en | - |
dc.publisher | 서울대학교 대학원 | - |
dc.subject | fibroblast growth factor-1 | - |
dc.subject | canine adipose tissue-derived mesenchymal stem cells | - |
dc.subject | conditioned medium | - |
dc.subject | diabetes mellitus | - |
dc.subject | insulin resistance | - |
dc.subject | in vitro | - |
dc.subject | 3T3-L1 | - |
dc.subject.ddc | 636.089 | - |
dc.title | Fibroblast growth factor-1 as a mediator of paracrine effects of canine adipose tissue-derived mesenchymal stem cells on in vitro-induced insulin resistance models | - |
dc.title.alternative | In vitro 인슐린 저항성 모델에 대한 개 지방유래중간엽줄기세포 paracrine 효과의 매개체 fibroblast growth factor-1 | - |
dc.type | Thesis | - |
dc.contributor.AlternativeAuthor | Hyeonjin Kim | - |
dc.description.degree | Master | - |
dc.contributor.affiliation | 수의과대학 수의학과 | - |
dc.date.awarded | 2018-02 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.